{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT05179954",
            "orgStudyIdInfo": {
                "id": "2097324"
            },
            "organization": {
                "fullName": "University of Missouri-Columbia",
                "class": "OTHER"
            },
            "briefTitle": "Lipoprotein Kinetics in T1D",
            "officialTitle": "Apolipoprotein C3-loading of Apolipoprotein B100 Lipoproteins and Cardiovascular Disease in Patients With Type 1 Diabetes",
            "acronym": "LTD",
            "therapeuticArea": [
                "Endocrinology"
            ],
            "study": "lipoprotein-kinetics-in"
        },
        "statusModule": {
            "statusVerifiedDate": "2023-10",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2022-05-09",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2025-12-31",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2027-12-31",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2021-11-22",
            "studyFirstSubmitQcDate": "2021-12-16",
            "studyFirstPostDateStruct": {
                "date": "2022-01-06",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2023-10-24",
            "lastUpdatePostDateStruct": {
                "date": "2023-10-27",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "PRINCIPAL_INVESTIGATOR",
                "investigatorFullName": "Bettina Mittendorfer",
                "investigatorTitle": "Senior Associate Dean for Research",
                "investigatorAffiliation": "University of Missouri-Columbia"
            },
            "leadSponsor": {
                "name": "University of Missouri-Columbia",
                "class": "OTHER"
            },
            "collaborators": [
                {
                    "name": "University of Washington",
                    "class": "OTHER"
                }
            ]
        },
        "oversightModule": {
            "isFdaRegulatedDrug": false,
            "isFdaRegulatedDevice": false
        },
        "descriptionModule": {
            "briefSummary": "The purpose of this research study is to understand how type 1 diabetes (T1D) increases the risk for cardiovascular diseases (heart attack and stroke). To this end, the investigators will compare apolipoprotein and triglyceride kinetics in people wtih T1D and healthy control participants.",
            "detailedDescription": "Not required"
        },
        "conditionsModule": {
            "conditions": [
                "Type 1 Diabetes"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "NA"
            ],
            "designInfo": {
                "allocation": "NON_RANDOMIZED",
                "interventionModel": "PARALLEL",
                "interventionModelDescription": "Cross-sectional comparison (T1D vs healthy control)",
                "primaryPurpose": "BASIC_SCIENCE",
                "maskingInfo": {
                    "masking": "NONE"
                }
            },
            "enrollmentInfo": {
                "count": 30,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "Control group",
                    "type": "OTHER",
                    "description": "Healthy control group",
                    "interventionNames": [
                        "Other: Metabolic testing"
                    ]
                },
                {
                    "label": "T1D group",
                    "type": "ACTIVE_COMPARATOR",
                    "description": "T1D group",
                    "interventionNames": [
                        "Other: Metabolic testing"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "OTHER",
                    "name": "Metabolic testing",
                    "description": "Participants will complete a metabolic testing protocol that includes intravenous infusion of stable isotope labeled tracers and blood sampling to determine lipoprotein kinetics",
                    "armGroupLabels": [
                        "Control group",
                        "T1D group"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Apolipoprotein C turnover rate",
                    "description": "Apolipoprotein C turnover rate will be assessed by using an intravenous stable isotope labeled amino acid infusion",
                    "timeFrame": "one time, at baseline (this is a cross-sectional, observational study, no intervention)"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "Triglyceride turnover rate",
                    "description": "Triglyceride turnover rate will be assessed by using an intravenous stable isotope labeled glycerol infusion",
                    "timeFrame": "one time, at baseline (this is a cross-sectional, observational study, no intervention)"
                },
                {
                    "measure": "Apolipoprotein B-100 turnover rate",
                    "description": "Apolipoprotein B-100 turnover rate will be assessed by using an intravenous stable isotope labeled amino acid infusion",
                    "timeFrame": "one time, at baseline (this is a cross-sectional, observational study, no intervention)"
                },
                {
                    "measure": "Apolipoprotein C concentration",
                    "description": "Apolipoprotein C concentration",
                    "timeFrame": "one time, at baseline (this is a cross-sectional, observational study, no intervention)"
                },
                {
                    "measure": "Triglyceride concentration",
                    "description": "Triglyceride concentration",
                    "timeFrame": "one time, at baseline (this is a cross-sectional, observational study, no intervention)"
                },
                {
                    "measure": "Apolipoprotein B-100 concentration",
                    "description": "Apolipoprotein B-100 concentration",
                    "timeFrame": "one time, at baseline (this is a cross-sectional, observational study, no intervention)"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n* Age: \u226518 but \u226445 years\n* premenopausal/eumenorrheic and not pregnant or breastfeeding\n* non-obese (body mass index \u226518.5\\<30.0 kg/m2)\n* Fasting plasma triglyceride \\<150 mg/dL\n\nAdditional inclusion criteria for control subjects:\n\n* Fasting plasma glucose \\<100 mg/dL\n* Plasma glucose 2 h after a 75 g oral glucose challenge \\<140 mg/dL\n* HbA1c \\<5.6%.\n\nAdditional inclusion criteria for subjects with T1DM:\n\n* stable insulin regimen (multiple daily insulin injections or continuous subcutaneous insulin) for at least 8 weeks before screening\n* no use of diabetes medications other than insulin\n* HbA1c \\<6.5%, basal (overnight fasted)\n* no severe symptomatic hypoglycemic event associated with a seizure or requiring help from other people or a medical facility in the 6 months prior to screening or metabolic testing\n\nExclusion Criteria:\n\n* more than 1.5 h of structured exercise/week\n* use of tobacco products, excessive amounts of alcohol, or dietary supplements and/or medications known to affect lipid metabolism\n* hypothyroidism or other disorders known to affect lipid metabolism\n* conditions that would make it impossible to complete the study protocol",
            "healthyVolunteers": true,
            "sex": "ALL",
            "minimumAge": "18 Years",
            "maximumAge": "45 Years",
            "stdAges": [
                "ADULT"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Bettina Mittendorfer",
                    "role": "CONTACT",
                    "phone": "314-362-8540",
                    "email": "mittendb@wustl.edu"
                }
            ],
            "overallOfficials": [
                {
                    "name": "Bettina Mittendorfer",
                    "affiliation": "Washington University School of Medicine",
                    "role": "PRINCIPAL_INVESTIGATOR"
                }
            ],
            "locations": [
                {
                    "facility": "University of Missouri School of Medicine",
                    "status": "RECRUITING",
                    "city": "Columbia",
                    "state": "Missouri",
                    "zip": "65212",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Bettina Mittendorfer, PhD",
                            "role": "CONTACT",
                            "email": "b.mittendorfer@missouri.edu"
                        }
                    ],
                    "geoPoint": {
                        "lat": 38.95171,
                        "lon": -92.33407
                    }
                }
            ]
        },
        "ipdSharingStatementModule": {
            "ipdSharing": "YES",
            "description": "De-identified data will be available upon reasonable request",
            "timeFrame": "5 years after completion of the study"
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000003922",
                    "term": "Diabetes Mellitus, Type 1"
                }
            ],
            "ancestors": [
                {
                    "id": "D000003920",
                    "term": "Diabetes Mellitus"
                },
                {
                    "id": "D000044882",
                    "term": "Glucose Metabolism Disorders"
                },
                {
                    "id": "D000008659",
                    "term": "Metabolic Diseases"
                },
                {
                    "id": "D000004700",
                    "term": "Endocrine System Diseases"
                },
                {
                    "id": "D000001327",
                    "term": "Autoimmune Diseases"
                },
                {
                    "id": "D000007154",
                    "term": "Immune System Diseases"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M7117",
                    "name": "Diabetes Mellitus, Type 1",
                    "asFound": "Type 1 Diabetes",
                    "relevance": "HIGH"
                },
                {
                    "id": "M7115",
                    "name": "Diabetes Mellitus",
                    "relevance": "LOW"
                },
                {
                    "id": "M11639",
                    "name": "Metabolic Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M25403",
                    "name": "Glucose Metabolism Disorders",
                    "relevance": "LOW"
                },
                {
                    "id": "M7862",
                    "name": "Endocrine System Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M4629",
                    "name": "Autoimmune Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M10200",
                    "name": "Immune System Diseases",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC18",
                    "name": "Nutritional and Metabolic Diseases"
                },
                {
                    "abbrev": "BC19",
                    "name": "Gland and Hormone Related Diseases"
                },
                {
                    "abbrev": "BC20",
                    "name": "Immune System Diseases"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                }
            ]
        }
    },
    "hasResults": false
}